Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study
Selçuk Altın, Tunç Ozan, Selçuk İlhan, Nevin İlhan, Rahmi Onur
(Urol Res Pract 2015; 41: 125-131) DOI: 10.5152/tud.2015.89656